Viewing Study NCT05886920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-07-07 @ 2:01 AM
Study NCT ID: NCT05886920
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2023-05-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
Sponsor: D3 Bio (Wuxi) Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumors With MAPK Pathway Mutations View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced solid tumors View
None mitogen-activated protein kinase View
None mutation View